Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Spectrum
gets FDA response letter on cancer drug 5:55 AM 10/9/2009
Reuters
Spectrum Pharmaceuticals' drug Fusilev is currently approved by the US FDA as a rescue
after high dose of methotrexate therapy in patients with osteosarcoma. The FDA has responded on its supplementary
marketing application for Fusilev to treat advanced metastatic colorectal cancer.
...
US
FDA panel recommends wider use of Pfizer HIV drug 2:59 PM 10/8/2009
Reuters
A US FDA advisory panel recommended Pfizer Inc's HIV drug Selzentry be
approved for wider use in patients who have a specific type of HIV-1.
...
Threshold
Pharma's Melanoma Drug Shows Promise In Trial 1:35 PM 10/8/2009
Wall Street
Journal
Threshold Pharmaceuticals Inc said interim data from trials of its hypoxia-activated prodrug
TH-302 melanoma treatment showed six of eight patients responded to the treatment.
...
Glaxo
seeks to overturn Genentech antibody patent 10:58 AM 10/8/2009
Reuters
GlaxoSmithKline has challengesd a biotech patent held by Roche's Genentech unit in a bid
to give a clear run to experimental cancer and arthritis drug Arzerra developed with Genmab.
...
IMS
sees brighter outlook for global drug sales 5:26 AM 10/8/2009
Reuters
IMS sees growth over 5 percent this year and 3 to 5 percent in 2010. Pharmacies are
forced to rebuild inventories while manufacturers raised prices.
...
Novartis
Gets Rights To Broad-Spectrum Antibiotic 5:16 AM 10/8/2009
Wall Street Journal
Novartis AG gained exclusive worldwide rights to market PTK 0796. It could
become the first once-a-day broad-spectrum antibiotic that can be given as a tablet or intravenously to treat
infections caused by drug-resistant bacteria.
...
Cancer,
bowel drugs on US FDA safety scrutiny list 5:50 PM 10/7/2009
Reuters
More than a dozen drugs are under scrutiny for potential side effects
including liver failure in patients treated with Pfizer's cancer drug Sutent and gastrointestinal perforation
reported with Relistor from Wyeth and Progenics Pharmaceuticals.
...
Vical
announces positive vaccine study update 2:31 PM 10/7/2009
Forbes
Biotechnology company Vical Inc said the TransVax cytomegalovirus vaccine designed for
stem cell transplant patients performed well in a midstage clinical trial.
...
Biotech
fundraising up amid vaccine hype, cash need 12:27 PM 10/7/2009
Reuters
Swine flu vaccine hype, pent-up demand for cash, and major drugmakers boosting flagging
research pipelines has helped lift biotechnology fund-raising 36 percent this year to $5.7 billion.
...
Genzyme
must further study drug 4:55 AM 10/7/2009
Boston
Globe
Genzyme Corp needs more data on leukemia drug Clolar before the US FDA will consider expanding the use
to previously untreated adults with acute myeloid leukemia.
...
Pfizer
HIV drug seems safe for new use - FDA staff 8:42 AM 10/6/2009
Reuters
Pfizer Inc's HIV drug Selzentry (maraviroc) appears to be safe for wider
use in certain patients who have not yet begun taking other antivirals.
...
OncoGenex
gets new fast-track status for cancer drug 6:41 AM 10/6/2009
Reuters
OncoGenex Pharmaceuticals Inc said the US FDA granted an additional
fast-track designation to its prostate cancer drug OGX-011 in combination with first-line chemotherapy.
...
EU
Court Sides With Drug Industry on Pricing 4:49 AM 10/6/2009
New York Times
Efforts to prevent traders from exploiting price differences across
Europe could be exempted from antitrust rules.
...
Vaccines
for drug addiction show promise 3:34 AM 10/6/2009
Los Angeles Times
A cocaine vaccine reduced use in nearly 40 percent of addicts. Nicotine,
heroin, and methamphetamine vaccines are on the horizon.
...
Depomed
says shingles pain drug meets study goal 6:49 PM 10/5/2009
The Associated Press
Depomed Inc reports successful late stage clinical trial of
drug DM-1796 intended to treat pain following the viral infection shingles.
...
<- Day Earlier | Today's News
|
